Center-Authored Papers

Filters: Author is Beauchamp, Geetha  [Clear All Filters]
B
Buchacz K, Farrior J, Beauchamp G, McKinstry L, Kurth AE, Zingman BS, Gordin FM, Donnell D, Mayer KH, El-Sadr WM et al..  2016.  Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention: Results from the HPTN 065 Study.. Journal of the International Association of Providers of AIDS Care. Abstract
C
Chen I, Zhang Y, Cummings V, Cloherty GA, Connor M, Beauchamp G, Griffith S, Rose S, Gallant J, Scott HM et al..  2017.  Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States.. AIDS research and human retroviruses. Abstract
Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, Khaki L, Koblin B, Chesney M, Moore RD et al..  2011.  Use of a High Resolution Melting (HRM) Assay to Compare Gag, Pol, and Env Diversity in Adults with Different Stages of HIV Infection.. PloS one. 6(11):e27211. Abstract
D
Donnell DJ, Hall IH, Gamble T, Beauchamp G, Griffin AB, Torian LV, Branson B, El-Sadr WM.  2012.  Use of HIV Case Surveillance System to Design and Evaluate Site-Randomized Interventions in an HIV Prevention Study: HPTN 065.. The open AIDS journal. 6:122-30. Abstract
E
El-Sadr WM, Donnell D, Beauchamp G, Hall IH, Torian LV, Zingman B, Lum G, Kharfen M, Elion R, Leider J et al..  2017.  Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065).. JAMA internal medicine. Abstract
J
Jackson BJ, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G et al..  2014.  Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand.. Hepatitis research and treatment. 2014:296958. Abstract
K
Kurth AE, Mayer K, Beauchamp G, McKinstry L, Farrior J, Buchacz K, Donnell D, Branson B, El-Sadr W.  2012.  Clinician Practices and Attitudes Regarding Early Antiretroviral Therapy in the US.. Journal of acquired immune deficiency syndromes (1999). 61(5):e65-69. Abstract
L
Levy ME, Phillips G, Magnus M, Kuo I, Beauchamp G, Emel L, Hucks-Ortiz C, Hamilton EL, Wilton L, Chen I et al..  2017.  A Longitudinal Analysis of Treatment Optimism and HIV Acquisition and Transmission Risk Behaviors Among Black Men Who Have Sex with Men in HPTN 061.. AIDS and behavior. Abstract
M
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Z
Zhang Y, Clarke W, Marzinke MA, Piwowar-Manning E, Beauchamp G, Breaud A, Hendrix CW, Cloherty GA, Emel L, Rose S et al..  2017.  Evaluation of a multi-drug assay for monitoring adherence to a regimen for HIV pre-exposure prophylaxis in a clinical study (HIV Prevention Trials Network 073).. Antimicrobial agents and chemotherapy. Abstract